TuHURA Biosciences, Inc. beat EPS estimates 67% of the time across 3 reported quarters (2 beats, 1 misses), averaging -1.5% versus consensus. Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result | Call |
|---|---|---|---|---|---|
| Q2 FY26 | $-0.15 | $-0.14 | +6.7% | Beat | |
| Q1 FY26 | $-0.11 | $-0.13 | -18.2% | Miss | |
| Q4 FY25 | $-0.14 | $-0.13 | +7.1% | Beat |
Back to HURA overview · HURA holders · HURA KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.